Discovery of Small Molecule Dual Inhibitors of Abeta and tau Aggregation using CCM technology

Time: 11:20 am
day: Track A - Day 1 AM


  • Development of an in-silico model (CCM) to identify small molecule inhibitors of protein misfolding
  • Description of the assay platform developed by Treventis to detect the earliest phases of intrinsically disordered protein aggregation
  • Presentation of in vivo target engagement of amyloid beta and tau oligomers